21-23 Phase 2/3 trials are currently evaluating whether GLP-1 RAs reduce illness progression in persons with mild cognitive impairment or amyloid-positive mild dementia due to Alzheimer disease (ie, semaglutide)
Symptoms include shakiness, sweating, hunger, anxiety, confusion, dizziness, blurred vision, and at the severe end, seizure or loss of consciousness
However, about half of the patients who take these drugs stop within a year because of unwanted side effects
Completely different operating environment
However, I wasnt sure if the supplements I normally used would be safe for nursing
Clinical Evidence Supporting Glutathione IV Therapy for Skin Brightening The use of IV Glutathione for skin tone modulation is supported by clinical pharmacology and published dermatological research